To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Oral cannabis did not affect dyskinesia in Parkinson's disease

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2018

Oral cannabis did not affect dyskinesia in Parkinson's disease

Vol: 7| Issue: 10| Number:63| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

Neurology. 2004 Oct 12;63(7):1245-50.

Contributing Authors:
X Liu D Wright CB Carroll Bain P.G. L Teare C Joint C Wroath SG Parkin P Fox J Hobart JP Zajicek

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

19 patients with Parkinson's disease and levodopa-induced dyskinesia completed a 4-week oral cannabis dose-escalation study followed by a randomized crossover trial of cannabis versus placebo (4 weeks each phase). The primary outcome was the Unified Parkinson's Disease Rating Scale dyskinesia score. There was no evidence of any effects on Parkinson's or dyskinesia symptoms. Cannabis was well-toler...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue